DALIA ELGAMAL

Assistant Professor

University of Nebraska Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Prakash Radhakrishnan

University of Nebraska Medical Center

UNITED STATES

View details

Grinu Mathew

University of Nebraska Medical Center

UNITED STATES

View details

Gloria E. O. Borgstahl

UNITED STATES

View details

Krishnaiah Maddeboina

Research Assistant Professor

Levine Cancer Institute

UNITED STATES

View details

Tatiana Kutateladze

Professor/Associate Professor/Assistant Professor

University of Colorado School of Medicine

UNITED STATES

View details

Amarnath Natarajan

Ruth Branham Professor of Cancer Research

University of Nebraska Medical Center

UNITED STATES

View details

Erin Drengler

University of Nebraska Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

DALIA ELGAMAL

Research Interests

Explore related searches

Contact this professor

Articles (11)

The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax

BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia.

Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects.

Defining the Role of the Gut Microbiome in the Pathogenesis and Treatment of Lymphoid Malignancies

Editorial for the IJMS Special Issue on Molecular Pathogenesis and Molecular Therapy of Lymphoid Malignancies

Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies.

A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia

Insect cell expression and purification of recombinant SARS-COV-2 spike proteins that demonstrate ACE2 binding.

Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma.

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma.

Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro.

Collaborators (7)

Prakash Radhakrishnan

Grinu Mathew

Gloria E. O. Borgstahl

Krishnaiah Maddeboina

Tatiana Kutateladze

Amarnath Natarajan

Erin Drengler

Make your next move.